Global Natamycin Market Growth 2025-2031

Global Natamycin Market Growth 2025-2031

The global Natamycin market size is predicted to grow from US$ 206 million in 2025 to US$ 303 million in 2031; it is expected to grow at a CAGR of 6.6% from 2025 to 2031.

Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.

Global Natamycin key players include Danisco, DSM, VGP, Handary, AMTECH BIOTECH, etc. Global top five players hold a share about 50%.

North America is the largest market, with a share about 35%, followed by Europe and China, having a total share about 35 percent.

In terms of product, the segment includes Glucose-based, Lactose-based, Sodium chloride-based. And in terms of application, the application includes Food Industry, Medical, etc.

LP Information, Inc. (LPI) ' newest research report, the “Natamycin Industry Forecast” looks at past sales and reviews total world Natamycin sales in 2024, providing a comprehensive analysis by region and market sector of projected Natamycin sales for 2025 through 2031. With Natamycin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Natamycin industry.

This Insight Report provides a comprehensive analysis of the global Natamycin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Natamycin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Natamycin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Natamycin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Natamycin.

This report presents a comprehensive overview, market shares, and growth opportunities of Natamycin market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Glucose-based
Lactose-based
Sodium chloride-based

Segmentation by Application:
Food
Medical
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Danisco
DSM
VGP
Handary
AMTECH BIOTECH
Silver-Elephant
Lanzhou Weiri
Langfang Meihua
Zhengzhou New Frey
Chihon
Jiaozuo Joincare
Beijing Oriental Rada
Pucheng Lifecome

Key Questions Addressed in this Report

What is the 10-year outlook for the global Natamycin market?

What factors are driving Natamycin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Natamycin market opportunities vary by end market size?

How does Natamycin break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.